Angelini Ventures
- United States
- Denmark
- France
- Italy
- Switzerland
- Canada
- Singapore
- Austria
- Germany
- Spain
- Portugal
- Poland
- Czech Republic
- Slovakia
- Hungary
- Romania
- Bulgaria
- Greece
- Turkey
- Sweden
- Holland
- Russia
- United Kingdom
- Belgium
- Ireland
- Seed
- Series A
- Series B
- Series C
- Digital Health
- Biotech
- Medtech
- Life Sciences
- Healthcare Innovation
Angelini Ventures is committed to advancing the future of global healthcare through investments in digital health, biotechnology, and medtech. Leveraging the heritage and domain expertise of the Angelini Group, the firm supports visionary founders developing transformative solutions that improve patient outcomes and modernize healthcare systems.
Investment Thesis
Manager's Experience
Team
Paolo Di Giorgio – CEO & Managing Director
Elia Stupka – Managing Director
Tanja Dowe – Managing Director
Regina Hodits – Managing Director
Gabriela Manrique – Partner
Fabrizio Calisti – Medical Director
Thomas Thestrup – Senior Principal
Nils Bottler – Principal
Cesar Montero – Finance Manager
Barbara Saulini – Executive Assistant
Natasa Ralevic – Data Scientist
Martina Palmese – Communications Coordinator
Maya Misra – Senior Analyst
Lola Buono – Senior Associate
Sarah Fox – Senior Associate
Daniel Bode – Associate
Portfolio
Nuclidium
Elkedonia
TheriniBio
Nuevocor
nobi
Vantis
NEUmiRNA
Nouscom
Avation Medical
Cour
Noctrix
Freya
Cadence Neuroscience
Serenis
Arclight Therapeutics
Damona Pharmaceuticals
Congruence
GenEp
Pretzel Therapeutics
Extend (venture studio)
Argobio (venture studio)